Filtros de búsqueda

Lista de obras de Andrey Maryandyshev

A comparison between passive and active case finding in TB control in the Arkhangelsk region.

scientific article published on 14 February 2014

Bedaquiline and Delamanid Combination Treatment of 5 Patients with Pulmonary Extensively Drug-Resistant Tuberculosis

artículo científico publicado en 2017

Cost minimization analysis of line probe assay for detection of multidrug-resistant tuberculosis in Arkhangelsk region of Russian Federation

artículo científico publicado en 2019

Diagnosis and treatment of patients with pulmonary nontuberculous mycobacterial diseases in Arkhangelsk, Russia

scientific article published on 01 June 2019

Drug-resistant tuberculosis threatens WHO's End-TB strategy

artículo científico publicado en 2017

Early access to bedaquiline for extensively drug-resistant (XDR) and pre-XDR tuberculosis

artículo científico publicado en 2019

Effectiveness and safety of bedaquiline-containing regimens in the treatment of MDR- and XDR-TB: a multicentre study.

artículo científico publicado en 2017

Epidemiological analyses of tuberculosis in Archangelsk, Russia and implementation of a rapid assay for detection of resistance in this high burden setting.

artículo científico publicado en 2013

Hopelessness as a basis for tuberculosis diagnostic delay in the Arkhangelsk region: a grounded theory study.

artículo científico publicado en 2013

Impact of drug resistance on fitness of Mycobacterium tuberculosis strains of the W-Beijing genotype.

artículo científico publicado en 2004

Impact of drug-resistant Mycobacterium tuberculosis on treatment outcome of culture-positive cases of tuberculosis in the Archangel oblast, Russia, in 1999

artículo científico publicado en 2004

Incidence of tuberculosis and associations with indicators of alcohol consumption in three regions of northwest Russia in 1975-2009: a time-series analysis.

artículo científico publicado en 2013

Molecular epidemiology and drug resistance of Mycobacterium tuberculosis isolates in the Archangel prison in Russia: predominance of the W-Beijing clone family.

artículo científico publicado en 2003

Outbreak of tuberculosis in a closed setting: views on transmission based on results from molecular and conventional methods.

artículo científico publicado en 2016

Outcomes of patients with drug-resistant-tuberculosis treated with bedaquiline-containing regimens and undergoing adjunctive surgery

artículo científico publicado en 2018

Resistance of multidrug-resistant strains of Mycobacterium tuberculosis from the Archangel oblast, Russia, to second-line anti-tuberculosis drugs.

artículo científico publicado en 2005

Risk factors for acquisition of drug resistance during multidrug-resistant tuberculosis treatment, Arkhangelsk Oblast, Russia, 2005-2010.

artículo científico publicado en 2015

The Impact of a Line Probe Assay Based Diagnostic Algorithm on Time to Treatment Initiation and Treatment Outcomes for Multidrug Resistant TB Patients in Arkhangelsk Region, Russia

artículo científico publicado en 2016

Treatment Outcomes in Global Systematic Review and Patient Meta-Analysis of Children with Extensively Drug-Resistant Tuberculosis

scientific article published on 01 March 2019

Treatment and outcomes in children with multidrug-resistant tuberculosis: A systematic review and individual patient data meta-analysis

artículo científico publicado en 2018

Tuberculosis in BRICS: challenges and opportunities for leadership within the post-2015 agenda.

artículo científico publicado en 2014

Tuberculosis in the Circumpolar Region, 2006-2012

artículo científico publicado en 2018

Two vicious circles contributing to a diagnostic delay for tuberculosis patients in Arkhangelsk.

artículo científico publicado en 2014

WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update

artículo científico publicado en 2011

What happened to patients with RMP-resistant/MDR-TB in Zambia reported as lost to follow-up from 2011 to 2014?

artículo científico publicado en 2017

[The main results of clinical trials of the efficacy, safety and pharmacokinetics of the perspective anti-tuberculosis drug makozinone (PBTZ169)]

artículo científico publicado en 2020